| |
|
Marker |
| Year |
Total Donor No. |
HBsAg |
HBcAb |
Anti-HCV |
Anti-HIV |
HBV DNA |
HCV RNA |
HIV RNA |
| |
|
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
No. |
% |
| 2011 |
3090 |
20 |
0.7 |
244 |
7.9 |
6 |
0.2 |
3 |
0.1 |
21 |
0.68 |
0 |
0 |
0 |
0 |
| 2012 |
5731 |
47 |
0.8 |
408 |
7.1 |
23 |
0.4 |
2 |
0.04 |
47 |
0.85 |
2 |
0.03 |
1 |
0.02 |
| 2013 |
6947 |
43 |
0.6 |
442 |
6.4 |
43 |
0.6 |
7 |
0.1 |
46 |
0.66 |
7 |
0.1 |
4 |
0.06 |
| 2014 |
7195 |
44 |
0.6 |
454 |
6.3 |
30 |
0.4 |
4 |
0.06 |
50 |
0.69 |
2 |
0.03 |
1 |
0.01 |
| Overall |
22963 |
154 |
0.7 |
1548 |
6.7 |
102 |
0.44 |
16 |
0.07 |
164 |
0.72 |
11 |
0.05 |
6 |
0.03 |
| Trend in numbers and prevalence of individual HBV, HCV, and HIV serological and nucleic acid markers among blood donors in Makkah from 2011 to 2014. |
|
